Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis
Although the BPaL regimen had a lower overall risk of DILI compared to the HRZE regimen, it was significantly associated with DILI, indicating a need for careful monitoring during treatment.
Authors
- Qingfeng He (ORCID: https://orcid.org/0000-0001-5795-1550)
- Xiaoqiang Xiang (ORCID: https://orcid.org/0000-0002-8683-2603)
- Sifan Liu (ORCID: https://orcid.org/0000-0002-1608-4216)
- Zhen Feng (ORCID: https://orcid.org/0000-0003-4090-5966)
- Yang Li (ORCID: https://orcid.org/0000-0003-4022-7341)
- Tao Wang (ORCID: https://orcid.org/0000-0001-9845-3988)
- Hao Xue (ORCID: https://orcid.org/0000-0003-4138-1447)
Institutions
- Xuzhou Medical College (CN)
- Chinese Academy of Sciences (CN)
- Fudan University (CN)
- Shanghai Institute of Materia Medica (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1111/bcp.16318
- Citations
- 3
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Natural Science Foundation of China